Literature DB >> 10572558

Clinical options for women at high risk for breast cancer.

L C Hartmann1, T A Sellers, D J Schaid, S Nayfield, C S Grant, J A Bjoraker, J Woods, F Couch.   

Abstract

Women at hereditary risk of breast cancer face a difficult clinical decision. Each of the options available to them has unique advantages and disadvantages that are summarized in Table 9. Many components enter a high-risk woman's decision: her objective risk of breast cancer; clinical features, such as the consistency of breast tissue and resultant ease of examination; breast density on mammography; personal characteristics, including her experience with cancer within her family; her role and [table: see text] responsibilities within her own nuclear family; her values and goals; her experiences with the medical system; and her subjective assessment of risk. It is generally believed that women significantly overestimate their risk of breast cancer. Thus, it is vital that a woman at risk have access to a genetic counselor who can provide accurate assessment of her risk. Women should be encouraged to take time to understand their risk level and the advantages and disadvantages of the options before them.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10572558     DOI: 10.1016/s0039-6109(05)70068-2

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  5 in total

1.  Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing.

Authors:  Vardit Kram; Tamar Peretz; Michal Sagi
Journal:  Fam Cancer       Date:  2006-05-25       Impact factor: 2.375

2.  Volume of mammographic density and risk of breast cancer.

Authors:  John A Shepherd; Karla Kerlikowske; Lin Ma; Frederick Duewer; Bo Fan; Jeff Wang; Serghei Malkov; Eric Vittinghoff; Steven R Cummings
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-24       Impact factor: 4.254

3.  Characterization of the pathogenic mechanism of a novel BRCA2 variant in a Chinese family.

Authors:  Ava Kwong; L P Wong; K Y K Chan; E S K Ma; U S Khoo; J M Ford
Journal:  Fam Cancer       Date:  2007-07-27       Impact factor: 2.375

4.  Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience.

Authors:  Laura Cortesi; Daniela Turchetti; Isabella Marchi; Antonella Fracca; Barbara Canossi; Battista Rachele; Ruscelli Silvia; Pecchi Anna Rita; Torricelli Pietro; Federico Massimo
Journal:  BMC Cancer       Date:  2006-08-17       Impact factor: 4.430

5.  mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer.

Authors:  Chao Cheng; Xuping Fu; Pedro Alves; Mark Gerstein
Journal:  Genome Biol       Date:  2009-09-01       Impact factor: 13.583

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.